The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Open accessAbstract
The present procedural guidelines summarize the current views of the EANM Neuro-Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting results of [18 F]FDG-PET imaging of the brain. The aim is to help achieve a high-quality standard of [18 F]FDG brain imaging and to further increase the diagnostic impact of this technique in neurological, neurosurgical, and psychiatric practice. The present document replaces a former version of the guidelines that have been published in 2009. These new guidelines include an update in the light of advances in PET technology such as the introduction of digital PET and hybrid PET/MR systems, advances in individual PET semiquantitative analysis, and current broadening clinical indications (e.g., for encephalitis and brain lymphoma). Further insight has also become available about hyperglycemia effects in patients who undergo brain [18 F]FDG-PET. Accordingly, the patient preparation procedure has been updated. Finally, most typical brain patterns of metabolic changes are summarized for neurodegenerative diseases. The present guidelines are specifically intended to present information related to the European practice. The information provided should be taken in the context of local conditions and regulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Brain Metabolism during Fasting*
Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,646
van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., & van den Berg, L. H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31287-4 · Cited by 1,298
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 951
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 744
Self-citationMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70057-1 · Cited by 716
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Kennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S., & Vaccarino, F. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.899 · Cited by 710
EANM/SNMMI Guideline for18F-FDG Use in Inflammation and Infection
Jamar, F., Buscombe, J., Chiti, A., Christian, P. E., Delbeke, D., Donohoe, K. J., Israel, O., Martin-Comin, J., & Signore, A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.112524 · Cited by 577
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Self-citationEANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Någren, K., Darcourt, J., Kapucu, Ö. L., Tatsch, K., Bartenstein, P., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1264-0 · Cited by 544
Self-citationPET: the merging of biology and imaging into molecular imaging.
Phelps, M. E. (2000) · PubMed · Cited by 531
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30314-8 · Cited by 526
Self-citationPerformance Characteristics of the Digital Biograph Vision PET/CT System
van Sluis, J., de Jong, J., Schaar, J., Noordzij, W., van Snick, P., Dierckx, R., Borra, R., Willemsen, A., & Boellaard, R. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215418 · Cited by 484
Self-citationVidebech, P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001011.x · Cited by 419
FDG PET in the differential diagnosis of parkinsonian disorders
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M. F., Feigin, A. S., & Eidelberg, D. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.012 · Cited by 419
The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy
Spencer, S. S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05990.x · Cited by 379
Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques
Hofmann, M., Pichler, B., Schölkopf, B., & Beyer, T. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1007-7 · Cited by 343
[18F]FDG PET signal is driven by astroglial glutamate transport
Zimmer, E. R., Parent, M. J., Souza, D. G., Leuzy, A., Lecrux, C., Kim, H.-I., Gauthier, S., Pellerin, L., Hamel, E., & Rosa-Neto, P. (2017) · Nature Neuroscience · doi:10.1038/nn.4492 · Cited by 343
Kaschten, B., Stevenaert, A., Sadzot, B., Deprez, M., Degueldre, C., Fiore, G. D., Luxen, A., & Reznik, M. (1998) · PubMed · Cited by 327
Thomas, B. A., Erlandsson, K., Modat, M., Thurfjell, L., Vandenberghe, R., Ourselin, S., & Hutton, B. F. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1745-9 · Cited by 316
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression
Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., Herscovitch, P., & Post, R. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01216-1 · Cited by 301
Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N. I., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04817-8 · Cited by 273
Self-citationXiang, X., Wind, K., Wiedemann, T., Blume, T., Shi, Y., Briel, N., Beyer, L., Biechele, G., Eckenweber, F., Zatcepin, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5640 · Cited by 268
Self-citationSignorini, M., Paulesu, E., Friston, K., Perani, D., Colleluori, A., Lucignani, G., Grassi, F., Bettinardi, V., Frackowiak, R. S. J., & Fazio, F. (1999) · NeuroImage · doi:10.1006/nimg.1998.0381 · Cited by 265
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Whitwell, J. L., Höglinger, G. U., Antonini, A., Bordelon, Y., Boxer, A. L., Colosimo, C., van Eimeren, T., Golbe, L. I., Kassubek, J., Kurz, C., et al. (2017) · Movement Disorders · doi:10.1002/mds.27038 · Cited by 260
Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
Brown, R. K. J., Bohnen, N. I., Wong, K. K., Minoshima, S., & Frey, K. A. (2014) · RadioGraphics · doi:10.1148/rg.343135065 · Cited by 256
Minoshima, S., Koeppe, R. A., Mintun, M. A., Berger, K. L., Taylor, S. F., Frey, K. A., & Kuhl, D. E. (1993) · PubMed · Cited by 255
Hoffman, J. M., Waskin, H. A., Schifter, T., Hanson, M. W., Gray, L. L., Rosenfeld, S., & Coleman, R. E. (1993) · PubMed · Cited by 253
Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System
Hsu, D. F. C., Ilan, E., Peterson, W. T., Uribe, J., Lubberink, M., & Levin, C. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189514 · Cited by 241
Ladefoged, C. N., Law, I., Anazodo, U., St. Lawrence, K., Izquierdo-Garcia, D., Catana, C., Burgos, N., Cardoso, M. J., Ourselin, S., Hutton, B., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.010 · Cited by 229
Self-citationImaging markers for Alzheimer disease: Which vs how
Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829d86e8 · Cited by 225
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Perani, D., Della Rosa, P. A., Cerami, C., Gallivanone, F., Fallanca, F., Vanoli, E. G., Panzacchi, A., Nobili, F., Pappatà, S., Marcone, A., et al. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.10.009 · Cited by 217
Self-citationBaumgartner, A., Rauer, S., Mader, I., & Meyer, P. T. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7048-2 · Cited by 214
Nobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., Walker, Z., Boccardi, M., & the EANM‐EAN Task Force for the Prescription of FDG‐PET for Dementing Neurodegenerative Disorders (2018) · European Journal of Neurology · doi:10.1111/ene.13728 · Cited by 211
Surgical outcome in PET‐positive, MRI‐negative patients with temporal lobe epilepsy
LoPinto‐Khoury, C., Sperling, M. R., Skidmore, C., Nei, M., Evans, J., Sharan, A., & Mintzer, S. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03359.x · Cited by 201
Thalamic metabolism and symptom onset in preclinical Huntington's disease
Feigin, A., Tang, C., Ma, Y., Mattis, P., Zgaljardic, D., Guttman, M., Paulsen, J. S., Dhawan, V., & Eidelberg, D. (2007) · Brain · doi:10.1093/brain/awm217 · Cited by 200
Abnormal metabolic networks in atypical parkinsonism
Eckert, T., Tang, C., Ma, Y., Brown, N., Lin, T., Frucht, S., Feigin, A., & Eidelberg, D. (2008) · Movement Disorders · doi:10.1002/mds.21933 · Cited by 192
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective
Biessels, G. J., Nobili, F., Teunissen, C. E., Simó, R., & Scheltens, P. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30139-3 · Cited by 188
Spence, A. M., Muzi, M., Mankoff, D. A., O’Sullivan, S., Link, J. M., Lewellen, T. K., Lewellen, B., Pham, P., Minoshima, S., Swanson, K. R., et al. (2004) · PubMed · Cited by 182
Burdette, J. H., Minoshima, S., Vander Borght, T., Tran, D. D., & Kuhl, D. E. (1996) · Radiology · doi:10.1148/radiology.198.3.8628880 · Cited by 174
Metabolic correlates of levodopa response in Parkinson’s disease
Feigin, A., Fukuda, M., Dhawan, V., Przedborski, S., Jackson–Lewis, V., Mentis, M. J., Moeller, J. R., & Eidelberg, D. (2001) · Neurology · doi:10.1212/wnl.57.11.2083 · Cited by 174
No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.
Hasselbalch, S. G., Knudsen, G. M., Videbaek, C., Pinborg, L. H., Schmidt, J. F., Holm, S., & Paulson, O. B. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1915 · Cited by 171
Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard
Rausch, I., Ruiz, A., Valverde-Pascual, I., Cal-González, J., Beyer, T., & Carrio, I. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215541 · Cited by 168
Laere, K. V., Vanhee, A., Verschueren, J., Coster, L. D., Driesen, A., Dupont, P. J., Robberecht, W., & Damme, P. V. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.62 · Cited by 160
The use of SPECT and PET in routine clinical practice in epilepsy
Van Paesschen, W., Dupont, P., Sunaert, S., Goffin, K., & Van Laere, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328042baf6 · Cited by 158
For the EANM/SNMMI Paediatric Dosage Harmonization Working Group, Laßmann, M., & Treves, S. T. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2731-9 · Cited by 158
Metabolic brain networks in translational neurology: Concepts and applications
Niethammer, M., & Eidelberg, D. (2012) · Annals of Neurology · doi:10.1002/ana.23631 · Cited by 157
FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: A longitudinal study
Initiative, O. B. O. A. D. N., Ou, Y.-N., Xu, W., Li, J.-Q., Guo, Y., Cui, M., Chen, K.-L., Huang, Y.-Y., Dong, Q., Tan, L., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0512-1 · Cited by 155
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy
Vinton, A., Carne, R. P., Hicks, R. J., Desmond, P. M., Kilpatrick, C. J., Kaye, A. H., & O'Brien, T. J. (2006) · Brain · doi:10.1093/brain/awl232 · Cited by 150
for the EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, Walker, Z., Gandolfo, F., Orini, S., Garibotto, V., Agosta, F., Arbizu, J., Bouwman, F. H., Drzezga, A. E., Nestor, P. J., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4031-2 · Cited by 146
Self-citationMild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
Caroli, A., Prestia, A., Galluzzi, S., Ferrari, C., van der Flier, W. M., Ossenkoppele, R., Van Berckel, B., Barkhof, F., Teunissen, C., Wall, A. E., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001209 · Cited by 142
Self-citationSpence, A. M., Muzi, M., Graham, M. M., O’Sullivan, F., Krohn, K. A., Link, J. M., Lewellen, T. K., Lewellen, B., Freeman, S. D., Berger, M. S., et al. (1998) · PubMed · Cited by 139
18 F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies
Whitwell, J. L., Graff‐Radford, J., Singh, T. D., Drubach, D. A., Senjem, M. L., Spychalla, A. J., Tosakulwong, N., Lowe, V. J., & Josephs, K. A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179903 · Cited by 139
A disease-specific metabolic brain network associated with corticobasal degeneration
Niethammer, M., Tang, C. C., Feigin, A., Allen, P. J., Heinen, L., Hellwig, S., Amtage, F., Hanspal, E. K., Vonsattel, J. P., Poston, K. L., et al. (2014) · Brain · doi:10.1093/brain/awu256 · Cited by 135
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Nestor, P. J., Altomare, D., Festari, C., Drzezga, A. E., Rivolta, J., Walker, Z., Bouwman, F. H., Orini, S., Law, I. G., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4035-y · Cited by 126
Self-citationProcedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
Schelbert, H. R., Hoh, C. K., Royal, H. D., Brown, M., Dahlbom, M. N., Dehdashti, F., & Wahl, R. L. (1998) · PubMed · Cited by 125
Metabolic network as a progression biomarker of premanifest Huntington’s disease
Tang, C. C., Feigin, A., Ma, Y., Habeck, C. G., Paulsen, J. S., Leenders, K. L., Teune, L. K., van Oostrom, J. C. H., Guttman, M., DHAWAN, V. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69411 · Cited by 125
Routine quality control recommendations for nuclear medicine instrumentation
Sokole, E. B., With contribution from the EANM Working Group on Nuclear Medicine Instrumentation Quality Control:, Płachcińska, A., Britten, A. J., Georgosopoulou, M. L., Tindale, W., & Klett, R. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1347-y · Cited by 124
Bordonné, M., Chawki, M. B., Doyen, M., Kas, A., Guedj, É., Tyvaert, L., & Verger, A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05299-y · Cited by 124
Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18 F-FDG
Hahn, A., Gryglewski, G., Nics, L., Hienert, M., Rischka, L., Vraka, C., Sigurdardottir, H., Vanicek, T., James, G. M., Seiger, R., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.176156 · Cited by 120
Yakushev, I. Y., Landvogt, C., Buchholz, H., Fellgiebel, A., Hammers, A., Scheurich, A., Schmidtmann, I. M., Gerhard, A., Schreckenberger, M., & Bartenstein, P. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.11.004 · Cited by 119
The FDG lumped constant in normal human brain.
Graham, M. M., Muzi, M., Spence, A. M., O’Sullivan, F., Lewellen, T. K., Link, J. M., & Krohn, K. A. (2002) · PubMed · Cited by 118
Drzezga, A. E., Arnold, S., Minoshima, S., Noachtar, S., Szecsi, J., Winkler, P., Römer, W., Tatsch, K., Weber, W., & Bartenstein, P. (1999) · PubMed · Cited by 115
Berding, G., Odin, P., Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., KOLBE, H., van den Hoff, J., Fricke, H., et al. (2001) · Movement Disorders · doi:10.1002/mds.1212 · Cited by 112
Eskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109 · cited 1×
“might, at least in theory, impact diagnostic accuracy [93, 94].”
BackgroundGok, B., Jallo, G. I., Hayeri, R., Wahl, R. L., & Aygün, N. (2012) · Neuroradiology · doi:10.1007/s00234-012-1121-x · Cited by 105
Normalization in PET group comparison studies—The importance of a valid reference region
Borghammer, P., Jónsdóttir, K. Ý., Cumming, P. D., Østergaard, K., Vang, K., Ashkanian, M., Vafaee, M., Iversen, P., & GJEDDE, A. H. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.057 · Cited by 103
Garibotto, V., Herholz, K., Boccardi, M., Picco, A., Varrone, A., Nordberg, A. K., Nobili, F. M., & Ratib, O. M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.033 · Cited by 101
Self-citationvan Sluis, J., Boellaard, R., Somasundaram, A., van Snick, J. H., Borra, R., Dierckx, R., Stormezand, G. N., Glaudemans, A. W. J. M., & Noordzij, W. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.227801 · Cited by 100
Self-citationCRANSTON, I. C., Marsden, P. K., Matyka, K. A., Evans, M. L., Lomas, J., Sönksen, P. H., Maisey, M. N., & Amiel, S. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199802000-00002 · Cited by 93
Effects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu, K., Nishizawa, S., Yonekura, Y., Sadato, N., Magata, Y., Tamaki, N., Tsuchida, T., Okazawa, H., Miyatake, S., & Ishikawa, M. (1994) · PubMed · Cited by 91
de Zwart, P. L., van Dijken, B. R. J., Holtman, G. A., Stormezand, G. N., Dierckx, R. A. J. O., van Laar, P. J., & van der Hoorn, A. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.233809 · Cited by 88
High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases.
Ohnishi, T., Hoshi, H., Nagamachi, S., Jinnouchi, S., Flores, L. G., Futami, S., & Watanabe, K. (1995) · PubMed · Cited by 85
Dupont, S., Semah, F., Clémenceau, S., Adam, C., Baulac, M., & Samson, Y. (2000) · Archives of Neurology · doi:10.1001/archneur.57.9.1331 · Cited by 84
Self-citationMorbelli, S. D., Brugnolo, A., Bossert, I., Buschiazzo, A., Frisoni, G. B., Galluzzi, S., van Berckel, B. N. M., Ossenkoppele, R., Perneczky, R., Drzezga, A. E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142229 · Cited by 82
Self-citationIntensity normalization methods in brain FDG-PET quantification
López‐González, F. J., Silva‐Rodríguez, J., Paredes‐Pacheco, J., Niñerola‐Baizán, A., Efthimiou, N., Martín‐Martín, C., Moscoso, A., Ruibal, Á., Roé-Vellvé, N., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117229 · Cited by 82
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan
Colavolpe, C., Chinot, O. L., Métellus, P., Mancini, J., Barrié, M., Bequet, C., Tabouret, É., MUNDLER, O., Figarella‐Branger, D., & Guedj, É. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos012 · Cited by 81
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse
Berman, S. M., Voytek, B., Mandelkern, M. A., Hassid, B. D., Isaacson, A. J., Monterosso, J. R., Miotto, K. A., Ling, W. W., & London, E. D. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002107 · Cited by 79
Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis
Morbelli, S. D., Djekidel, M., Hesse, S., Pagani, M., & Barthel, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30140-5 · Cited by 78
Self-citationIshii, K., Kono, A. K., Sasaki, H., Miyamoto, N., Fukuda, T., Sakamoto, S., & Mori, E. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0015-0 · Cited by 76
18 FDG‐PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value
Guedj, É., Bonini, F., Gavaret, M., Trébuchon, A., Aubert, S., Boucékine, M., Boyer, L., Carron, R., McGonigal, A., & Bartoloméi, F. (2015) · Epilepsia · doi:10.1111/epi.12917 · Cited by 75
Ladefoged, C. N., Hansen, A. E., Henriksen, O. M., Bruun, F. J., Eikenes, L., Øen, S. K., Karlberg, A. M., Højgaard, L., Law, I. G., & Andersen, F. L. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117221 · Cited by 73
Self-citationClinical, FDG and amyloid PET imaging in posterior cortical atrophy
Singh, T. D., Josephs, K. A., Machulda, M. M., Drubach, D. A., Apostolova, L. G., Lowe, V. J., & Whitwell, J. L. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7732-5 · Cited by 72
Ciarmiello, A., Giovacchini, G., Orobello, S., Bruselli, L., Elifani, F., & Squitieri, F. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2114-z · Cited by 68
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG ‐ PET
Iaccarino, L., Sala, A., Perani, D., & Initiative, T. A. D. N. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.782 · Cited by 67
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia
Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Schwarz, C. G., Reid, R. I., Baker, M., Perkerson, R. B., Lowe, V. J., et al. (2015) · Brain and Language · doi:10.1016/j.bandl.2015.01.009 · Cited by 62
Volkow, N. D., Wang, G., Kojori, E. S., Fowler, J. S., Benveniste, H., & Tomasi, D. G. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4877-14.2015 · Cited by 61
Weehaeghe, D. V., Ceccarini, J., Delva, A., Robberecht, W., Damme, P. V., & Laere, K. V. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166272 · Cited by 61
Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
Initiative, A. D. N., Tan, M., Xi, J., Li, J., Xu, W., Wang, H.-F., Tan, C., Dong, Q., Zuo, C., Tan, L., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00621-6 · Cited by 61
Hasselbalch, S. G., Madsen, P. L., Knudsen, G. M., Holm, S., & Paulson, O. B. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199802000-00005 · Cited by 59
Kono, A. K., Ishii, K., Sofue, K., Miyamoto, N., Sakamoto, S., & Mori, E. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0380-y · Cited by 59
For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Nobili, F. M., Festari, C., Altomare, D., Agosta, F., Orini, S., Laere, K. V., Arbizu, J., Bouwman, F. H., Drzezga, A. E., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4030-3 · Cited by 59
Verbal memory in left temporal lobe epilepsy: Evidence for task‐related localization
Weintrob, D. L., Saling, M. M., Berkovic, S. F., Berlangieri, S. U., & Reutens, D. C. (2002) · Annals of Neurology · doi:10.1002/ana.10133 · Cited by 57
18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
Townley, R. A., Botha, H., Graff‐Radford, J., Boeve, B. F., Petersen, R. C., Senjem, M. L., Knopman, D. S., Lowe, V. J., Jack, C. R., & Jones, D. T. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.02.031 · Cited by 56
Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
Endres, D., Rauer, S., Kern, W. V., Venhoff, N., Maier, S. J., Runge, K., Süß, P., Feige, B., Nickel, K., Heidt, T., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01086 · Cited by 54
Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy
Lagarde, S., Boucékine, M., McGonigal, A., Carron, R., Scavarda, D., Trébuchon, A., Milh, M., Boyer, L., Bartoloméi, F., & Guedj, É. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04791-1 · Cited by 54
Chen, S., Hu, P., Gu, Y., Yu, H., & Shi, H. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00315-w · Cited by 54
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas
Colavolpe, C., Métellus, P., Mancini, J., Barrié, M., Bequet, C., Figarella‐Branger, D., MUNDLER, O., Chinot, O. L., & Guedj, É. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0771-6 · Cited by 53
Verger, A., Grimaldi, S., Ribeiro, M. J., Frismand, S., & Guedj, É. (2021) · Annals of Neurology · doi:10.1002/ana.26187 · Cited by 53
Caminiti, S. P., Sala, A., Presotto, L., Chincarini, A., Sestini, S., Perani, D., for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), F. T. A. I. M. N. (. D., Schillaci, O., Berti, V., Calcagni, M. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05175-1 · Cited by 52
Self-citationYang, J., Hu, C., Guo, N., Dutta, J., Vaina, L. M., Johnson, K. A., Sepulcre, J., Fakhri, G. E., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-13339-7 · Cited by 51
Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia
Nestor, P. J., Balan, K., Cheow, H. K., Fryer, T. D., Knibb, J. A., Xuereb, J. H., & Hodges, J. R. (2007) · Neurology · doi:10.1212/01.wnl.0000251309.54320.9f · Cited by 50
Pagani, M., Öberg, J., Carli, F. D., Calvo, A., Moglia, C., Canosa, A., Nobili, F. M., Morbelli, S. D., Fania, P., Cistaro, A., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.23078 · Cited by 50
Self-citationMorbelli, S. D., Arbizu, J., Booij, J., Chen, M.-K., Chételat, G., Cross, D. J., Djekidel, M., Drzezga, A. E., Ekmekçioğlu, Ö., Garibotto, V., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3589-9 · Cited by 50
Self-citationGe, J., Wu, J., Peng, S., Wu, P., Wang, J., Zhang, H., Guan, Y., Eidelberg, D., Zuo, C., & Ma, Y. (2018) · Human Brain Mapping · doi:10.1002/hbm.24044 · Cited by 50
Herholz, K., Pietrzyk, U., Karbe, H., Würker, M., Wienhard, K., & Heiss, W. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90202-x · Cited by 49
Sarikaya, İ., Sarıkaya, A., & Sharma, P. N. (2019) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.119.226969 · Cited by 49
Lehman, V. T., Carter, R. E., Claassen, D. O., Murphy, R. C., Lowe, V. J., Petersen, R. C., & Peller, P. J. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182478d89 · Cited by 48
Salat, D. H., Robinson, M. E., Miller, D. R., Clark, D. C., & McGlinchey, R. E. (2017) · Brain Injury · doi:10.1080/02699052.2017.1327672 · Cited by 48
Technical and instrumentational foundations of PET/MRI
Rausch, I., Quick, H. H., Cal-González, J., Sattler, B., Boellaard, R., & Beyer, T. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.004 · Cited by 47
Self-citationGeneralized decrease in brain glucose metabolism during fasting in humans studied by PET
Redies, C., Hoffer, L. J., Beil, C., Marliss, E. B., Evans, A. C., Larivière, F., Marrett, S., Meyer, E., Dikšić, M., GJEDDE, A. H., et al. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.6.e805 · Cited by 46
Harmonisation of PET/CT contrast recovery performance for brain studies
Verwer, E. E., Golla, S. S. V., Kaalep, A., Lubberink, M., van Velden, F. H. P., Bettinardi, V., Yaqub, M. M., Séra, T., Rijnsdorp, S., Lammertsma, A. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05201-w · Cited by 45
Self-citationSalvadori, J., Imbert, L., Perrin, M., Karcher, G., Lamiral, Z., Marie, P.-Y., & Verger, A. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0526-5 · Cited by 44
Bordonné, M., Chawki, M. B., Marie, P., Zaragori, T., Roch, V., Grignon, R., Imbert, L., & Verger, A. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00334-7 · Cited by 43
Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria
Martí‐Andrés, G., van Bommel, L., Meles, S. K., Riverol, M., Valenti‐Azcarate, R., Kogan, R. V., Renken, R. J., Gurvits, V., van Laar, T., Pagani, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28217 · Cited by 42
Brain metabolic signatures across the Alzheimer’s disease spectrum
Sala, A., Caprioglio, C., Santangelo, R., Vanoli, E. G., Iannaccone, S., Magnani, G., & Perani, D. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04559-2 · Cited by 41
Perfusion and metabolism imaging studies in Parkinson's disease.
Borghammer, P. (2012) · PubMed · Cited by 40
Zhang, H., Wu, P., Ziegler, S. I., Guan, Y., Wang, Y., Ge, J., Schwaiger, M., Huang, S., Zuo, C., Förster, S., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.09.031 · Cited by 35
Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease
Scheltens, N. M. E., van der Weijden, K., Adriaanse, S. M., van Assema, D. M. E., Oomen, P. P., Krudop, W. A., Lammertsma, A. A., Barkhof, F., Koene, T., Teunissen, C. E., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.05.024 · Cited by 35
Self-citationHenry, T. R., & Votaw, J. R. (2004) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2004.04.011 · Cited by 32
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Bouwman, F. H., Orini, S., Gandolfo, F., Altomare, D., Festari, C., Agosta, F., Arbizu, J., Drzezga, A. E., Nestor, P. J., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4034-z · Cited by 32
Self-citationClinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Agosta, F., Altomare, D., Festari, C., Orini, S., Gandolfo, F., Boccardi, M., Arbizu, J., Bouwman, F. H., Drzezga, A. E., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4033-0 · Cited by 32
Ladefoged, C. N., Andersen, F. L., Kjær, A., Højgaard, L., & Law, I. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00453 · Cited by 31
Self-citationPeralta, C., Biafore, F. L., Depetris, T. S., & Bastianello, M. J. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0966-3 · Cited by 31
Mecheter, I., Alić, L., Abbod, M., Amira, A., & Ji, J. (2020) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-020-00361-x · Cited by 31
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington’s disease
Herben-Dekker, M., van Oostrom, J. C. H., Roos, R. A. C., Jurgens, C. K., Witjes‐Ané, M. W., Kremer, H. P. H., Leenders, K. L., & Spikman, J. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7350-7 · Cited by 30
Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics
Weehaeghe, D. V., Devrome, M., Schramm, G., Vocht, J. D., Deckers, W., Baete, K., Damme, P. V., Koole, M. J. B., & Laere, K. V. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04786-y · Cited by 30
Wagatsuma, K., Sakata, M., Ishibashi, K., Hirayama, A., Kawakami, H., Miwa, K., Suzuki, Y., & Ishii, K. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00337-4 · Cited by 29
Gjerum, L., Frederiksen, K. S., Henriksen, O. M., Law, I. G., Anderberg, L., Andersen, B. B., Bjerregaard, E., Hejl, A., Høgh, P., & Hasselbalch, S. G. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116645 · Cited by 28
Self-citationInitiative, A. D. N., Apostolova, I. I., Lange, C., Suppa, P., Spies, L., Klutmann, S., Adam, G., Grothe, M. J., & Buchert, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3985-4 · Cited by 27
Functional brain connectome in posterior cortical atrophy
Migliaccio, R., Agosta, F., Basaia, S., Cividini, C., Habert, M., Kas, A., Montembeault, M., & Filippi, M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102100 · Cited by 26
Gupta, T., Manjali, J. J., Kannan, S., Purandare, N. C., & Rangarajan, V. (2021) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2021.03.011 · Cited by 26
Verger, A., Malbos, É., Reynaud, E., Mallet, P., Mestre, D., Pergandi, J.-M., Khalfa, S., & Guedj, É. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0446-9 · Cited by 24
Chen, Y., Ying, C., Binkley, M. M., Juttukonda, M. R., Flores, S. E., Laforest, R. A., Benzinger, T. L. S., & An, H. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28689 · Cited by 24
Liu, S., Wang, Y., Xu, K., Ping, F., Li, F., Wang, R., & Cheng, X. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.10.038 · Cited by 22
Leiris, N. D., Ruel, B., Vervandier, J., Boucraut, J., Grimaldi, S., Horowitz, T., Pelletier, J., Fluchère, F., Campion, J., Initiative, A. D. N., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05507-9 · Cited by 22
Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain
Mortensen, K. N., GJEDDE, A. H., Thompson, G. J., Hermán, P., Parent, M. J., Rothman, D. L., Kupers, R. C., Ptito, M., Stender, J., Laureys, S., et al. (2018) · Neural Plasticity · doi:10.1155/2018/6120925 · Cited by 21
Rousseau, P., Malbos, É., Verger, A., Nicolas, F., Lançon, C., Khalfa, S., & Guedj, É. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04360-1 · Cited by 20
Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
Chen, W. P., Matsunari, I., Noda, A., Yanase, D., Yajima, K., Takeda, N., Yamada, M., Minoshima, S., & Nishimura, S. (2005) · PubMed · Cited by 19
Akanuma, N., Reed, L. J., Marsden, P. K., Jarosz, J., Adachi, N., Hallett, W. A., Alarcón, G., Morris, R. G., & Koutroumanidis, M. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21035 · Cited by 18
Byun, M. S., Kim, H. J., Yi, D., Choi, H. J., Baek, H., Lee, J. H., Choe, Y. M., Lee, S. H., Ko, K., Sohn, B. K., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101765 · Cited by 16
Hellem, M. N. N., Vinther‐Jensen, T., Anderberg, L., Budtz–Jørgensen, E., Hjermind, L. E., Larsen, V. A., Nielsen, J. E., & Law, I. G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252683 · Cited by 15
Self-citationFinding our way through the labyrinth of dementia biomarkers
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Lammertsma, A. A., Law, I. G., Morbelli, S. D., van de Giessen, E., & Drzezga, A. E. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05301-7 · Cited by 14
Self-citationViglianti, B. L., Wale, D. J., Ma, T., Johnson, T. D., Bohnen, N. I., Wong, K. K., Ky, C., Frey, K. A., Townsend, D. M., Rubello, D., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108628 · Cited by 11
The Use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia
Ortner, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_14 · Cited by 9
Validation of PET/MRI attenuation correction methodology in the study of brain tumours
Luca, F. D., Bolin, M., Blomqvist, L., Wassberg, C., Martin, H., & Delgado, A. F. (2020) · BMC Medical Imaging · doi:10.1186/s12880-020-00526-8 · Cited by 6
Garibotto, V., Trombella, S., Antelmi, L., Bosco, P., Redolfi, A., Tabouret-Viaud, C., Rager, O., Gold, G., Giannakopoulos, P., Morbelli, S. D., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210212162443 · Cited by 6
Self-citationEffect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging
Henriksen, O. M., Holm, S., Marner, L., & Law, I. G. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001281 · Cited by 5
Self-citation
Cited by
Boccalini, C., Ribaldi, F., Hristovska, I., Arnone, A., Peretti, D. E., Mu, L., Scheffler, M., Perani, D., Frisoni, G. B., & Garibotto, V. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13355 · Cited by 82
Self-citationRogeau, A., Hives, F., Bordier, C., Lahousse, H., Roca, V., Lebouvier, T., Pasquier, F., Huglo, D., Semah, F., & Lopes, R. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120530 · Cited by 29
Self-citationHeyer, S., Simon, M., Doyen, M., Mortada, A., Roch, V., Jeanbert, E., Thilly, N., Malaplate, C., Kearney-Schwartz, A., Jonveaux, T., et al. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01535-3 · Cited by 14
Metadata
- Authors
- Guedj, E., Varrone, A., Boellaard, R., Albert, N. L., Barthel, H., van Berckel, B., Brendel, M., Cecchin, D., Ekmekcioglu, O., Garibotto, V., Lammertsma, A. A., Law, I., Peñuelas, I., Semah, F., Traub-Weidinger, T., van de Giessen, E., Van Weehaeghe, D., & Morbelli, S.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2021-12-09
- Volume
- 49
- Issue
- 2
- Pages
- 632-651
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W4200308765
- Cited by
- 300
- References
- 155
- FWCI
- 18.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.